The Tryptophan Hydroxylase 1 (TPH1) gene, schizophrenia susceptibility, and suicidal behavior: A multi-centre case-control study and meta-analysis

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 2, 2010, Pages 387-396

  Saetre, Peter ^a   Lundmark, Per ^b   Wang, August ^c   Hansen, Thomas ^c,d   Rasmussen, Henrik B ^c   Djurovic, Srdjan ^e,f   Melle, Ingrid ^e,f   Andreassen, Ole A ^e,f   Werge, Thomas ^c   Agartz, Ingrid ^a,e,g   Hall, Håkan ^a   Terenius, Lars ^a   Jönsson, Erik G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c Mental Health Services CPH   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF OSLO   (Norway)

^f ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^g DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

Case control association study; Metaanalysis; Schizophrenia; Suicidal behavior; Tryptophan hydroxylase 1 gene (TPH1)

Indexed keywords

ADULT; ARTICLE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; CLINICAL TRIAL; FEMALE; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INSURANCE; INTRON; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; META ANALYSIS; PRIORITY JOURNAL; SCANDINAVIA; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; SYSTEMATIC REVIEW; TRYPTOPHAN HYDROXYLASE 1 GENE;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SEROTONIN; SUICIDE; SUICIDE, ATTEMPTED; TRYPTOPHAN HYDROXYLASE;

EID: 77349098812     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30991     Document Type: Article

References (67)

1. Abi-Dargham A. 2007. Alterations of serotonin transmission in schizophrenia. Int Rev Neurobiol 78:133-164.
2. Aghajanian GK. 1994. Electrophysiological studies on the actions of hallucinogenic drugs at 5-HT2 receptors in rat brain. NIDA Res Monogr 146:183-202.
3. Allen NC, Bagade S, McQueen MB, Ioannidis JPA, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L. 2008. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database. Nature Genet 40:827-834.
4. Anisman H, Du L, Palkovits M, Faludi G, Kovacs GG, Szontagh-Kishazi P, Merali Z, Poulter MO. 2008. Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects. J Psychiatry Neurosci 33:131-141.
5. Arango V, Underwood MD, Gubbi AV, Mann JJ. 1995. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 688:121-133.
6. Åsberg M. 1997. Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies. Ann NY Acad Sci 836:158-181. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265. Beautrais AL, Joyce PR, Mulder RT, FergussonDM,Deavoll BJ, Nightingale SK. 1996. Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: A case-control study. Am J Psychiatry 153:1009-1014.
7. Bellivier F, Leboyer M, Courtet P, Buresi C, Beaufils B, Samolyk D, Alliaire J-F, Feingold J, Mallet J, Malafosse A. 1998. Association between the tryptophan hydroxylase gene and manic-depressive illness. Arch Gen Psychiatry 55:33-37.
8. Bellivier F, Chaste P, Malafosse A. 2004. Association between the TPH gene A218C polymorphism and suicidal behavior: A meta-analysis.Am J Med Genet Part B 124B:87-91.
9. Burnet PW, Eastwood SL, Harrison PJ. 1996. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology 15:442-455.
10. Carlborg A, Jokinen J, Jönsson EG, Nordström A-L, Nordström P. 2008. Long term suicide risk in schizophrenia spectrum psychosis: Survival analysis by gender. Arch Suicide Res 12:347-351.
11. Chao HM, Richardson MA. 2002. Aromatic amino acid hydroxylase genes and schizophrenia. Am J Med Genet 114:626-630.
12. Chotai J, Serretti A, Lattuada E, Lorenzi C, Lilli R. 2003. Gene-environment interaction in psychiatric disorders as indicated by season of birth variations in tryptophan hydroxylase (TPH), serotonin transporter (5-HTTLPR) and dopamine receptor (DRD4) gene polymorphisms. Psychiatry Res 119:99-111.
13. Cote F, Thevenot E, Fligny C, Fromes Y, Darmon M, Ripoche MA, Bayard E, Hanoun N, Saurini F, Lechat P, Dandolo L, Hamon M, Mallet J, Vodjdani G. 2003. Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function. Proc Natl Acad Sci USA 100:13525-13530.
14. Courtet P, Jollant F, Castelnau D, Buresi C, Malafosse A. 2005. Suicidal behavior: Relationship between phenotype and serotonergic genotype. Am J Med Genet Part C 133C:25-33.
15. Dean B, Hussain T, Hayes W, Scarr E, Kitsoulis S, Hill C, Opeskin K, Copolov DL. 1999. Changes in serotonin2A and GABA(A) receptors in schizophrenia: Studies on the human dorsolateral prefrontal cortex. J Neurochem 72:1593-1599.
16. DerSimonian R, Laird N. 1986. Meta-analysis in clinical trials. Control Clin Trials 7:177-188.
17. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25:115-121.
18. Dudbridge F. 2008. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66:87-98.
19. Egger M, Davey Smith G, Schneider M, Minder C. 1997. Bias in metaanalysis detected by a simple, graphical test. Br Med J 315:629-634.
20. Fu Q, Heath AC, Bucholz KK, Nelson E, Goldberg J, Lyons MJ, True WR, Jacob T, Tsuang MT, Eisen SA. 2002a. Shared genetic risk of major depression, alcohol dependence, and marijuana dependence: Contribution of antisocial personality disorder in men. Arch Gen Psychiatry 59:1125-1132.
21. Fu Q, Heath AC, Bucholz KK, Nelson EC, Glowinski AL, Goldberg J, Lyons MJ, Tsuang MT, Jacob T, True MR, Eisen SA. 2002b. A twin study of genetic and environmental influences on suicidality in men. Psychol Med 32:11-24.
22. Furlong RA, Ho L, Rubinsztein JS, Walsh C, Paykel ES, Rubinsztein DC. 1998. No association of the tryptophan hydroxylase gene with bipolar affective disorder, unipolar affective disorder, or suicidal behavior in major affective disorder. Am J Med Genet 81:245-247.
23. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. 2002. The structure of haplotype blocks in the human genome. Science 296:2225-2229.
24. Hansen T, Olsen L, Lindow M, Jakobsen KD, Ullum H, Jonsson E, Andreassen OA, Djurovic S, Mjelle I, Agartz I, Hall H, Timm S, Wang AG, Werge T. 2007. Brain expressed microRNAs implicated in schizophrenia etiology. PLoS ONE 2:e873.
25. Hawton K, Sutton L, Haw C, Sinclair J, Deeks JJ. 2005. Schizophrenia and suicide: Systematic review of risk factors. Br J Psychiatry 187:9-20.
26. Ho LW, Furlong RA, Rubinsztein JS, Walsh C, Paykel ES, Rubinsztein DC. 2000. Genetic associations with clinical characteristics in bipolar affective disorder and recurrent unipolar depressive disorder. Am J Med Genet 96:36-42.
27. Hong CJ, Shih JT, Ying CW. 2001. Association between tryptophan hydroxylase gene polymorphism (A218C) and schizophrenic disorders. Schizophr Res 49:59-63.
28. Jöonsson EG, Larsson K, Vares M, Hansen T, Wang AG, Djurovic S, Rønningen KS, Andreassen OA, Agartz I, Werge T, Terenius L, Hall H. 2008a. Two methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms, schizophrenia and bipolar disorder: An association study. Am J Med Genet Part B 147B:976-982.
29. Jöonsson EG, Saetre P, Edman-Ahlbom B, Sillén A, Gunnar A, Andreou D, Agartz I, Sedvall G, Hall H, Terenius L. 2008b. Brain-derived neurotrophic factor gene variation influences cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol concentrations in healthy volunteers. J Neural Transm 115:1695-1699.
30. Kähler A, Djurovic S, Kulle B, Jönsson EG, Agartz I, Hall H, Opjordsmoen S, Jakobsen KD, Hansen T, Melle I, Steen VM, Werge T, Andreassen OA. 2008. Association analysis of schizophrenia on 18 candidate genes involved in neuronal migration: MGDA1 as a new susceptibility gene. Am J Med Genet Part B 147B:1089-1100.
31. Koller G, Engel RR, Preuss UW, Karakesisoglou A, Zill P, Bondy B, Soyka M. 2005. Tryptophan hydroxylase gene 1 polymorphisms are not associated with suicide attempts in alcohol-dependent individuals. Addict Biol 10:269-273.
32. Kunugi H, Ishida S, Kato T, Sakai T, Tatsumi M, Hirose T, Nanko S. 1999. No evidence for an association of polymorphisms of the tryptophan hydroxylase gene with affective disorders or attempted suicide among Japanese patients. Am J Psychiatry 156:774-776.
33. Li D, HeL. 2006. Further clarification of the contribution of the tryptophan hydroxylase (TPH) gene to suicidal behavior using systematic allelic and genotypic meta-analyses. Hum Genet 119:233-240.
34. Lichtenstein P, Yip BH, Björk C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM. 2009. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study. Lancet 373:234-239.
35. Lieberman JA, Mailman RB, Duncan G, Sikich L, Chakos M, Nichols DE, Kraus JE. 1998. Serotonergic basis of antipsychotic drug effects in schizophrenia. Biol Psychiatry 44:1099-1117.
36. Liu X, Li H, Qin W, He G, Li D, Shen Y, Shen J, Gu N, Feng G, He L. 2006. Association ofTPH1 with suicidal behaviour and psychiatric disorders in the Chinese population. J Med Genet 43:e4.
37. Mann JJ, Malone KM. 1997. Cerebrospinal fluid amines and higher lethality suicide attempts in depressed inpatients. Biol Psychiatry 41:162-171.
38. Mann JJ, Malone KM, Nielsen DA, Goldman D, Erdos J, Gelernter J. 1997. Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior. Am J Psychiatry 154:1451-1453.
39. Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, Dwork AJ, Arango V. 2000. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57: 729-738.
40. Matsumoto I, Inoue Y, Iwazaki T, Pavey G, Dean B. 2005. 5-HT2A and muscarinic receptors in schizophrenia: A postmortem study. Neurosci Lett 379:164-168.
41. Nakamura K, Sugawara Y, Sawabe K, Ohashi A, Tsurui H, Xiu Y, Ohtsuji M, Lin QS, Nishimura H, Hasegawa H, Hirose S. 2006. Late developmental stage-specific role of tryptophan hydroxylase 1 in brain serotonin levels. J Neurosci 26:530-534.
42. Nielsen DA, Goldman D, Virkkunen M, Tokola R, Rawlings R, Linnoila M. 1994. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch Gen Psychiatry 51:34-38.
43. Nielsen DA, Virkkunen M, Lappalainen J, Eggert M, Brown GL, Long JC, Goldman D, Linnoila M. 1998. A tryptophan hydroxylase gene marker for suicidality and alcoholism. Arch Gen Psychiatry 55:593-602.
44. Paik I, Toh K, Kim J, Lee C. 2000.TPH gene may be associated with suicidal behavior, but not with schizophrenia in the Korean population. Human Heredity 50:365-369.
45. Palmer BA, Pankratz VS, Bostwick JM. 2005. The lifetime risk of suicide in schizophrenia: A reexamination. Arch Gen Psychiatry 62:247-253.
46. Palomo T, Kostrzewa RM, Beninger RJ, Archer T. 2007. Genetic variation and shared biological susceptibility underlying comorbidity in neuropsychiatry. Neurotoxicity Res 12:29-42.
47. Rind HB, Russo AF, Whittemore SR. 2000. Developmental regulation of tryptophan hydroxylase messenger RNA expression and enzyme activity in the raphe and its target fields. Neuroscience 101:665-677.
48. Rujescu D, Giegling I, Sato T, Hartmann AM, Moller HJ. 2003. Genetic variations in tryptophan hydroxylase in suicidal behavior: Analysis and meta-analysis. Biol Psychiatry 54:465-473.
49. Sakowski SA, Geddes TJ, Thomas DM, Levi E, Hatfield JS, Kuhn DM. 2006. Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies. Brain Res 1085:11-18.
50. Savelieva KV, Zhao S, Pogorelov VM, Rajan I, Yang Q, Cullinan E, Lanthorn TH. 2008. Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants. PLoS ONE 3:e3301.
51. Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel P, Lesage AS, De Loore K, Leysen JE. 1996. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding. Psychopharmacology (Berl) 124:57-73.
52. Sekizawa T, Iwata Y, Nakamura K, Matsumoto H, Suzuki A, Suzuki K, Sekine Y, Takei N, Minabe Y, Mori N. 2004. Childhood-onset schizophrenia and tryptophan hydroxylase gene polymorphism. Am J Med Genet B Neuropsychiatr Genet 128(1):24-26.
53. Semwal P, Prasad S, Varma PG, Bhagwat AM, Deshpande SN, Thelma BK. 2002. Candidate gene polymorphisms among North Indians and their association with schizophrenia in a case-control study. J Genet 81:65-71.
54. Serretti A, Lilli R, Lorenzi C, Lattuada E, Cusin C, Smeraldi E. 2001. Tryptophan hydroxylase gene and major psychoses. Psychiatry Res 103:79-86.
55. Shaffer D, Gould MS, Fisher P, Trautman P, Moreau D, Kleinman M, Flory M. 1996. Psychiatric diagnosis in child and adolescent suicide. Arch Gen Psychiatry 53:339-348.
56. Shinkai T, Ohmori O, Suzuki T, Kojima H, Hori H, Terao T, Nakamura J. 2000. Polymorphisms of tryptophan hydroxylase gene and the symptomatology of schizophrenia: An association study. Psychiatr Genet 10:165-171.
57. Sodhi MS, Sanders-Bush E. 2004. Serotonin and brain development. Int Rev Neurobiol 59:111-174.
58. Souery D, Van Gestel S, Massat I, Blairy S, Adolfsson R, Blackwood D, Del-Favero J, Dikeos D, Jakovljevic M, Kaneva R, Lattuada E, Lerer B, Lilli R, Milanova V, Muir W, Nothen M, Oruc L, Papadimitriou G, Propping P, Schulze T, Serretti A, Shapira B, Smeraldi E, Stefanis C, Thomson M, Van Broeckhoven C, Mendlewicz J. 2001. Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders: A multicenter association study. Biol Psychiatry 49:405-409.
59. Tandon R, Keshavan MS, Nasrallah HA. 2008. Schizophrenia, "Just the Facts" What we know in 2008. 2. Epidemiology and etiology. Schizophr Res 102:1-18. Tsai SJ, Hong CJ, Wang YC. 1999. Tryptophan hydroxylase gene polymorphism (A218C) and suicidal behaviors. Neuroreport 10:3773-3775.
60. Viana MM, De Marco LA, Boson WL, Romano-Silva MA, Correa H. 2006. Investigation of A218C tryptophan hydroxylase polymorphism: Association with familial suicide behavior and proband's suicide attempt characteristics. Genes Brain Behav 5:340-345.
61. Watanabe Y, Nunokawa A, Kaneko N, Someya T. 2007. The tryptophan hydroxylase 1 (TPH1) gene and risk of schizophrenia: A moderatescale case-control study and meta-analysis. Neurosci Res 59:322-326.
62. Wigginton JE, Abecasis GR. 2005. PEDSTATS: Descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 21:3445-3447.
63. Wilson ST, Stanley B, Brent DA, Oquendo MA, Huang YY, Mann JJ. 2009. The tryptophan hydroxylase-1 A218C polymorphism is associated with diagnosis, but not suicidal behavior, in borderline personality disorder. Am J Med Genet B Neuropsychiatr Genet 150B(2):202-208.
64. Yip BH, Björk C, Lichtenstein P, Hultman CM, Pawitan Y. 2008. Covariance component models for multivariate binary traits in family data analysis. Stat Med 27:1086-1105.
65. Zaboli G, Gizatullin R, Nilsonne Å , Wilczek A, Jönsson EG, Ahnemark E, Åsberg M, Leopardi R. 2006a. Tryptophan hydroxylase (TPH) 1 gene variants associate with a group of suicidal borderline women. Neuropsychopharmacology 31:1982-1990.
66. Zaboli G, Jönsson EG, Gizatullin R, Åsberg M, Leopardi R. 2006b. Tryptophan hydroxylase-1 gene variants associated with schizophrenia. Biol Psychiatry 60:563-569.
67. Zill P, Buttner A, Eisenmenger W, Moller HJ, Ackenheil M, Bondy B. 2007. Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: A post-mortem study. J Psychiatr Res 41:168-173.